about
Signaling pathways in the molecular pathogenesis of adenocarcinomas of the esophagus and gastroesophageal junctionIncreased CDX2 and decreased PITX1 homeobox gene expression in Barrett's esophagus and Barrett's-associated adenocarcinomaRetinoic acid receptor-alpha messenger RNA expression is increased and retinoic acid receptor-gamma expression is decreased in Barrett's intestinal metaplasia, dysplasia, adenocarcinoma sequence.Predictors of response after laparoscopic splenectomy for immune thrombocytopenic purpura.Prevalence of Helicobacter pylori infection in 160 patients with Barrett's oesophagus or Barrett's adenocarcinoma.Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis.High Expression of Cathepsin E in Tissues but Not Blood of Patients with Barrett's Esophagus and AdenocarcinomaDifferential SPARC mRNA expression in Barrett's oesophagus.Identification of the CIMP-like subtype and aberrant methylation of members of the chromosomal segregation and spindle assembly pathways in esophageal adenocarcinoma.Effect of Laparoscopic Sleeve Gastrectomy on Fasting Gastrointestinal, Pancreatic, and Adipose-Derived Hormones and on Non-Esterified Fatty Acids.Decreased Levels of Circulating Cancer-Associated Protein Biomarkers Following Bariatric Surgery.Changes in gene expression of neo-squamous mucosa after endoscopic treatment for dysplastic Barrett's esophagus and intramucosal adenocarcinoma.Robot-assisted gastrectomy and oesophagectomy for cancer.Robot-assisted oesophageal and gastric surgery for benign disease: antireflux operations and Heller's myotomy.Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma.Gene expression alterations in formalin-fixed, paraffin-embedded Barrett esophagus and esophageal adenocarcinoma tissues.Emerging Concepts for the Endoscopic Management of Superficial Esophageal Adenocarcinoma.The prognostic value of TP53 mutations in oesophageal adenocarcinoma: a systematic review and meta-analysis.Physiologic basis for the treatment of epiphrenic diverticulum.Effectiveness of HSV-tk suicide gene therapy driven by the Grp78 stress-inducible promoter in esophagogastric junction and gastric adenocarcinomas.Long-term outcomes of a primary complete endoscopic resection strategy for short-segment Barrett's esophagus with high-grade dysplasia and/or early esophageal adenocarcinoma.MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett's esophagus.Anorectal surgery in patients infected with human immunodeficiency virus: factors associated with delayed wound healing.Is adenocarcinoma following esophagoduodenostomy without carcinogen in the rat reflux-induced?Glutathione S-transferase-pi expression is downregulated in patients with Barrett's esophagus and esophageal adenocarcinoma.Novel Aberrations Uncovered in Barrett's Esophagus and Esophageal Adenocarcinoma Using Whole Transcriptome Sequencing.The effects of weight loss and gastric banding on the innate and adaptive immune system in type 2 diabetes and prediabetes.Subcutaneous and visceral adipose tissue FTO gene expression and adiposity, insulin action, glucose metabolism, and inflammatory adipokines in type 2 diabetes mellitus and in health.Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus.Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival.Survival, mortality and morbidity outcomes after oesophagogastric cancer surgery in New South Wales, 2001-2008.Absence of gastroesophageal reflux disease in a majority of patients taking acid suppression medications after Nissen fundoplication.Upregulation of ornithine decarboxylase mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.Carditis: a manifestation of gastroesophageal reflux disease.Reduced arterial stiffness after weight loss in obese type 2 diabetes and impaired glucose tolerance: the role of immune cell activation and insulin resistance.Images of interest. Gastrointestinal: complications of fundoplication.Safety and Effectiveness of an Endoscopically Placed Duodenal-Jejunal Bypass Device (EndoBarrier®): Outcomes in 114 Patients.Bariatric Surgery Provides a "Bridge to Transplant" for Morbidly Obese Patients with Advanced Heart Failure and May Obviate the Need for Transplantation.Cholecystectomy in cardiothoracic organ transplant recipients.Immune cell-mediated inflammation and the early improvements in glucose metabolism after gastric banding surgery.
P50
Q27026253-4423D421-377B-4BDB-9D22-B822E050910DQ28282119-BF59901D-E196-47DB-9A7B-9C2E98140184Q32083580-C29CC5C6-C89A-4DD1-B22E-D9D1263CD398Q33337316-91AD153B-F244-427A-86D9-05925BE13216Q33851569-58298554-2E0F-49F9-9816-0E2B2564DF2CQ34445264-3DD481F2-17EF-4224-80FA-5D4D56B35365Q35690679-DD92386C-1C1C-48E8-B0D4-3E76B5D3E5DDQ36671256-1B31EB69-0AB5-4E50-9794-A40B970FD3E1Q36725997-3C7A24C3-8058-4E72-857B-13B789718643Q37587252-F5AFBBE1-EBDE-4EBE-A397-18B6E3269012Q37639541-8F0C9393-D24C-4C19-AC1E-1438D93C1CB0Q37741832-659BE10E-201F-40EA-B3FB-85F6D44F793DQ38204488-F5DE1E0A-1D1C-412B-8E59-68009A429972Q38231409-8F7FC1D8-BAB7-4B15-B0C1-D46DD8CD0E18Q38328606-D36F5F68-097B-4265-8004-A3C7D811A338Q38416120-582D04B9-D333-4F04-A2C4-B68D45D290F9Q38675582-4268D1D8-EA18-4E44-862A-D3992BE7FB54Q38687715-6CFC2C6E-D550-46E8-B276-33CB36281758Q39409723-0EDB8400-8DF5-4ED1-954C-DE967FBDB5FDQ39874418-45EC1A9A-68F8-4535-B34D-69F39EA6B0D8Q40813910-ED49BDBA-7584-411D-82A4-EE8EFCC39F4FQ41426289-2D86E9FF-6557-4F1A-A223-B97032BDC9BCQ41550013-2A3DFD19-7B17-474E-A78B-7B9D40234D53Q41739568-1CBB3FA6-D760-4D63-B27A-6828FB038581Q42521612-96178D2A-D0A7-457E-B385-6818AD0A1ABBQ42777211-0989D061-8323-4F6E-9668-4CCDA759F144Q43106768-8EAD2F3F-D39A-41D7-BED7-034DF5F42C04Q43274873-86082418-83C7-4824-81A7-B68F72BF4BF4Q44183470-041EE342-5F7B-4F05-B529-6D58898891F6Q44563546-1BB45754-A210-4510-BE57-E5A295300AC0Q45390291-9F76E1CD-5226-486E-ABAB-147233869E6EQ46077874-A8CF71C5-29D0-4214-8E74-7128C05BD81CQ46103035-3E738D02-5F00-4641-A77B-8E5080651D11Q46165823-0A267698-9CD8-4E51-B003-41151800D8CCQ46169707-A36152D9-68F6-4D89-9399-15C0A9C6F658Q46229416-914D2B25-564D-40D7-A10C-1881DBA594D2Q47581286-B35ADAC3-019F-4D51-82C9-90AA275C6D2DQ47677805-9363D4D5-7862-4CD2-97C5-71CCB8336AF8Q50153671-5531DC5C-4627-4DE4-BE84-5096B20BCB70Q51332960-0C154176-71E6-4C3E-B3B9-CD8A862DDA91
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Reginald V Lord
@ast
Reginald V Lord
@en
Reginald V Lord
@es
Reginald V Lord
@nl
type
label
Reginald V Lord
@ast
Reginald V Lord
@en
Reginald V Lord
@es
Reginald V Lord
@nl
prefLabel
Reginald V Lord
@ast
Reginald V Lord
@en
Reginald V Lord
@es
Reginald V Lord
@nl
P108
P106
P1153
7201583449
P31
P496
0000-0001-7475-492X